CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 110,738	$ 149,627
Accounts receivable	358,341	359,896
Inventory	125,362	123,095
Prepaid and other current assets	37,490	37,440
Total current assets	631,931	670,058
Equipment and other fixed assets, net	473,056	398,577
Operating lease right-of-use assets	128,635	147,760
Goodwill	3,524,999	3,512,567
Identifiable intangible assets, net	172,772	202,231
Other assets	20,453	15,098
Deferred tax assets	286,135	304,193
Total Assets	5,237,981	5,250,484
Current liabilities:
Accounts payable and accrued expenses	346,920	358,384
Current portion of finance lease obligations	2,695	15,446
Current portion of operating lease obligations	28,769	31,418
Current portion of long-term debt	30,000	20,000
Contract liabilities	31,605	31,370
Other liabilities	26,938	43,194
Total current liabilities	466,927	499,812
Long-term debt, less current portion	2,162,088	2,183,552
Operating lease obligations, less current portion	103,859	120,180
Other long-term liabilities	306,641	322,487
Warrant liability	38,516	57,764
Total Liabilities	3,078,031	3,183,795
Commitments and contingencies (note 14)
Stockholders' Equity:
Common Stock, par value of $0.0001 per share, 300,000,000 shares authorized; 134,723,174 and 133,843,732 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	13	13
Preferred Stock, par value of $0.0001 per share, 5,000,000 shares authorized; 124,060 and 124,060 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	1	1
Treasury stock, at cost (750,835 shares)	(13,992)
Additional paid-in capital	2,126,468	2,107,267
Retained earnings (Accumulated deficit)	28,883	(43,021)
Accumulated other comprehensive income (loss)	12,994	(2,354)
Total stockholders' equity attributable to AdaptHealth Corp.	2,154,367	2,061,906
Noncontrolling interests in subsidiaries	5,583	4,783
Total Stockholders' Equity	2,159,950	2,066,689
Total Liabilities and Stockholders' Equity	$ 5,237,981	$ 5,250,484